The estimated Net Worth of Joseph Jimenez is at least $5.91 million dollars as of 31 July 2015. Mr. Jimenez owns over 32,000 units of Procter & Gamble Co stock worth over $5,565,440 and over the last 15 years he sold PG stock worth over $0. In addition, he makes $349,375 as Independent Director at Procter & Gamble Co.
Joseph has made over 1 trades of the Procter & Gamble Co stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 32,000 units of PG stock worth $1,018,880 on 31 July 2015.
The largest trade he's ever made was buying 32,000 units of Procter & Gamble Co stock on 31 July 2015 worth over $1,018,880. On average, Joseph trades about 464 units every 0 days since 2010. As of 31 July 2015 he still owns at least 32,000 units of Procter & Gamble Co stock.
You can see the complete history of Mr. Jimenez stock trades at the bottom of the page.
Joseph S. Jimenez is an Independent Director of the Company. Mr. Jimenez is Co-Founder and Managing Partner of Aditum Bio (a biotech venture fund that launched in July 2019). He is the former Chief Executive Officer of Novartis AG (global healthcare company), a position he held from 2010 to 2018. Prior to this role, he held several other senior positions at Novartis from April 2007 to 2010, as well as various leadership roles at H. J. Heinz Company in Europe and North America from 1999 to 2006 and at ConAgra Foods from 1993 to 1998. He was also an Advisor to the Blackstone Group L.P. from 2006 to 2007. Mr. Jimenez has been a Director of General Motors since 2015. He was a Director of Colgate-Palmolive from 2010 to 2015. Mr. Jimenez’s demonstrated track record of International business Leadership, Strategy, and Risk Management and the Digital, Technology, and Innovation experience he gained through his role as CEO of Novartis and other roles at a range of Consumer Industry/Retail companies, such as H.J. Heinz and ConAgra, enables him to provide unique perspective to the Board on commercial, innovation, Marketing, and strategic issues. The Board also benefits from Mr. Jimenez’s extensive knowledge of the healthcare industry, particularly as the Company works to integrate Merck KGaA’s Consumer Health Business.
As the Independent Director of Procter & Gamble Co, the total compensation of Joseph Jimenez at Procter & Gamble Co is $349,375. There are 11 executives at Procter & Gamble Co getting paid more, with David Taylor having the highest compensation of $22,905,100.
Joseph Jimenez is 60, he's been the Independent Director of Procter & Gamble Co since 2018. There are 12 older and 23 younger executives at Procter & Gamble Co. The oldest executive at Procter & Gamble Co. is Nelson Peltz, 78, who is the Independent Director.
Joseph's mailing address filed with the SEC is ONE PROCTER & GAMBLE PLAZA, , CINCINNATI, OH, 45202.
Over the last 19 years, insiders at Procter & Gamble Co have traded over $3,894,676,988 worth of Procter & Gamble Co stock and bought 6,769 units worth $466,837 . The most active insiders traders include Nelsontrian Fund Management..., Margaret C Whitman et Scott D Cook. On average, Procter & Gamble Co executives and independent directors trade stock every 5 days with the average trade being worth of $7,758,919. The most recent stock trade was executed by Jon R Moeller on 28 August 2024, trading 37,240 units of PG stock currently worth $6,289,464.
The Procter & Gamble Company is an American multinational consumer goods corporation headquartered in Cincinnati, Ohio, founded in 1837 by William Procter and James Gamble.
Procter & Gamble Co executives and other stock owners filed with the SEC include: